Taiho Oncology, Inc.
Douglas Sigler has over 30 years of experience in information security and finance. Currently serving as the Executive Director of Information Security at Taiho Oncology, Inc., Douglas leads information security initiatives. Previous roles include Chief Information Security Officer at Alvarez & Marsal, where responsibilities encompassed information security and privacy, and Sr. Director of Information Security at WebMD. Douglas has also held director positions at KGB_ and Receivable Management Services, where key achievements included implementing security solutions aligned with business objectives and obtaining PCI compliance. Douglas began the career in finance with roles at DUN & BRADSTREET and Metropolitan Life Insurance Company. Education includes an MBA in Corporate Finance from Fairleigh Dickinson University and a Bachelor of Science from Bloomsburg University of Pennsylvania.
This person is not in the org chart
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com